<DOC>
	<DOCNO>NCT01027702</DOCNO>
	<brief_summary>The purpose study determine ability donor lymphocyte infusion ( DLI ) give methotrexate hasten immune recovery without cause severe graft-versus-host disease ( GVHD ) recipients T-cell deplete transplant .</brief_summary>
	<brief_title>Donor Lymphocyte Infusion After Alternative Donor Transplantation</brief_title>
	<detailed_description>Studies show give donor T cell mismatch T cell-depleted stem cell transplant speed recovery T cell patient . This approach cause severe graft versus host disease ( GVHD ) . The purpose study determine whether give donor lymphocyte infusion ( DLI ) methotrexate accelerate immune recovery recipient T cell-depleted stem cell transplant . Thirty day T-cell deplete transplant , patient give DLI . They monitor immune recovery measure CD4 count GVHD toxicity . Patients separate six cohort base dose DLI receive : 3 x 10^4 , 4 x 10^4 , 5 x 10^4 , 6 X 10^4 , 8 x 10^4 , 10 X10^4 cells/ kg body weight . A minimum 3 patient test dose start low dose . Dose escalation continue dose associate CD4 count &gt; 100 Day +120 transplant without significant GVHD determine . All patient receive thirteen dos methotrexate DLI prevent GVHD . Patients follow 2 year outcomes .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Patients must treat LCH BMT 0901 protocol Signed informed consent patient legal guardian Active GVHD time DLI due History acute GVHD &gt; grade I prior DLI Disease due viral infection ( eg . CMV ) DLI due ( asymptomatic viral replication viral shed contraindication ) Uncontrolled bacterial fungal infection O2 saturation pulse oximetry &lt; 95 % Bilirubin &gt; 3mg/dL ALT &gt; 5 x upper limit normal Creatinine &gt; 3x baseline ( transplant ) ANC ( WBC x % neutrophils + band ) &lt; 500/ul Significant effusion ( eg . pleural pericardial ) ascites EBVrelated PTLD Persistent increase mixed chimerism require therapeutic DLI define LCH BMT 0901 protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Donor Lymphocyte Infusion</keyword>
	<keyword>Immune Recovery</keyword>
	<keyword>T cell deplete transplant</keyword>
	<keyword>Mismatched relate donor transplant</keyword>
	<keyword>Unrelated donor transplant</keyword>
</DOC>